MedPath

BIRT-2584-XX

Generic Name
BIRT-2584-XX

Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2014-10-09
Last Posted Date
2014-10-09
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
55
Registration Number
NCT02259894

Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Midazolam in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2014-10-06
Last Posted Date
2014-10-06
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
20
Registration Number
NCT02256748

Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis

Phase 2
Completed
Conditions
Psoriasis
Interventions
Drug: Placebo
First Posted Date
2006-06-05
Last Posted Date
2014-06-19
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
360
Registration Number
NCT00333411
Locations
🇫🇷

HĂ´pital Dupuytren, Limoges cedex 1, France

🇩🇪

Otto-von-Guericke-Universität Magdeburg, Magdeburg, Germany

🇩🇪

Johannes Gutenberg-Universität Mainz, Mainz, Germany

and more 36 locations
© Copyright 2025. All Rights Reserved by MedPath